15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
Posts Tagged ‘NASDAQ:ITCI’
12 Best Psychedelic Stocks to Buy in 2025
In contrast to drugs like cocaine or marijuana, psychedelics are strong and give users access to a kind of "alternate reality." One class of hallucinogenic substances that can...
Why These 15 Stocks Are Skyrocketing in 2025
Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward tech innovation.
Why These 10 Large-Cap Stocks are Skyrocketing
On January 23, Mike Bailey, FBB Capital Partners director of research, appeared on CNBC where he shared his outlook on the large caps.
Jim Cramer Recently Discussed These 15 Stocks & The California Wildfires
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the devastation ushered in by the California wildfire calamity, social media CEO Mark Zuckerberg...
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q3 2024 Earnings Call Transcript
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q3 2024 Earnings Call Transcript October 30, 2024Intra-Cellular Therapies, Inc. misses on earnings expectations.
10 Most Promising Mid-Cap Stocks According to Hedge Funds
September closed on a high note, opening a wealth of opportunities for investors.
10 Best Mid-Cap Healthcare Stocks To Buy Now
According to projections by ReportLinker, the market for healthcare services will increase from $7.5 trillion in 2022 to $7.975 trillion in 2023.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q2 2024 Earnings Call Transcript
Operator: Good morning ladies and gentlemen and welcome to Intra-Cellular Therapies Second Quarter 2024 Earnings Conference Call.
Hedge Funds Like Intra-Cellular Therapies (NASDAQ:ITCI)
The healthcare industry is considered to be a fairly defensive sector due to its need.
7 Best Mid-Cap Healthcare Stocks To Buy Now
The healthcare industry is considered to be a fairly defensive sector due to its need.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Intra-Cellular Therapies' First Quarter 2024 Earnings Conference Call.
5 Best Russell 2000 Stocks To Buy According To Hedge Funds
In this article, we discuss 5 best Russell 2000 stocks to buy.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2023 Earnings Call Transcript
Intra-Cellular Therapies, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.44. Intra-Cellular Therapies, Inc.
16 Best Mid-Cap Growth Stocks To Buy Now
In this article, we will take a detailed look at the 16 Best Mid-Cap Growth Stocks To Buy Now. For a quick overview of such stocks, read our article 5 Best Mid-Cap Growth...
5 Best Psychedelic Stocks to Buy
In this article, we discuss 5 of the best psychedelic stocks to buy according to hedge funds.
5 Most Promising Psychedelic Stocks According to Hedge Funds
In this piece, we will take a look at the five most promising psychedelic stocks according to hedge funds.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Intra-Cellular Therapies 3Q 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q2 2023 Earnings Call Transcript
Operator: Good morning. And welcome to Intra-Cellular Therapies Second Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2023 Earnings Call Transcript
Operator: Good morning and welcome to Intra-Cellular Therapies First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
12 Most Promising Healthcare Stocks According to Analysts
In this article, we will take a look at the 12 most promising healthcare stocks according to analysts.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2022 Earnings Call Transcript
Operator: Thank you for standing by and welcome to the Intra-Cellular Therapies Fourth Quarter 2022 Earnings Conference Call.
5 High Growth Healthcare Stocks to Buy
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) is one of the high growth healthcare companies that is working on treatments for neuropsychiatric and neurologic disorders.
Is Intra-Cellular Therapies (ITCI) a Worthy Investment Option?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter investor letter.
Should You Retain Your Holdings in Intra-Cellular Therapies (ITCI)?
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Ultra Strategy” third-quarter 2022 investor letter.
Is Intra-Cellular Therapies (ITCI) Stock a Worthy Buy?
ClearBridge Investments, an investment management company, published its “ClearBridge Small Cap Growth Strategy” third quarter 2022 investor letter.
Wasatch Global’s Strongest Q1 Contributor: Intra-Cellular Therapies (ITCI)
Wasatch Global Investors, an investment management firm, published its “Wasatch Ultra Growth Fund” first quarter 2022 investor letter – a copy of which can be downloaded...
Is it a Great Choice to Invest in Intra-Cellular Therapies, Inc. (ITCI)?
ClearBridge Investments, an investment management firm, published its “Small Cap Strategy” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Should You Consider Investing in Intra-Cellular Therapies (ITCI)?
Wasatch Global Investors, an investment management firm, published its “Wasatch Small Cap Growth Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded...
Hedge Funds Are Warming Up To Intra-Cellular Therapies Inc (ITCI)
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Should You Consider Investing in Intra-Cellular Therapies (ITCI)?
Wasatch Global Investors, an investment management firm, published its “Wasatch Ultra Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded...
Is ITCI Stock A Buy or Sell?
In this article we will check out the progression of hedge fund sentiment towards Intra-Cellular Therapies Inc (NASDAQ:ITCI) and determine whether it is a good investment right...
Did Hedge Funds Make The Right Call On Intra-Cellular Therapies Inc (ITCI)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Do Hedge Funds Love Intra-Cellular Therapies Inc (ITCI)?
In this article you are going to find out whether hedge funds think Intra-Cellular Therapies Inc (NASDAQ:ITCI) is a good investment right now.
Intra-Cellular Therapies Inc (ITCI): Are Hedge Funds Right About This Stock?
We hate to say this but, we told you so.
5 Stocks Financial Advisors Are Looking To Buy This Week
All three main indexes appreciated last week as investors maintained a bullish sentiment following positive news in the last several weeks.
Did Hedge Funds Drop The Ball On Intra-Cellular Therapies Inc (ITCI) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Have Never Been Less Bullish On Intra-Cellular Therapies Inc (ITCI)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Here is What Hedge Funds Think About Intra-Cellular Therapies Inc (ITCI)
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Hedge Fund and Insider Trading News: Sahm Adrangi, Bernard Selz, Stryker Corporation (SYK), VBI Vaccines Inc (VBIV), and More
Kerrisdale Capital, the US hedge fund that made a public enemy of Neil Woodford after shorting two of his prominent holdings, is no longer making bets against companies backed...
Hedge Fund and Insider Trading News: Neil Woodford, Falcon Edge Capital, Alma Capital, Intra-Cellular Therapies Inc (ITCI), Ormat Technologies Inc (ORA), and More
LONDON (Reuters) - The suspension of Neil Woodford’s flagship fund has put the focus on a little known firm tasked with ensuring his investors were being looked after properly...
Here’s What Hedge Funds Think About Intra-Cellular Therapies Inc (ITCI)
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by spending enormous resources...
Is Intra-Cellular Therapies Inc (ITCI) A Good Stock To Buy?
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying for a while now that the current market is overvalued due to a low interest rate environment...
13D Filing: Alafi Capital Co LLC and Intra-Cellular Therapies Inc. (ITCI)
person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d...
10 Stocks Insiders and Hedge Funds Are Crazy About (part 1)
Insider activity provides a sneak peek to the future prospects of the company as this activity is based on the transactions made by executives and directors having exclusive and...
Intra-Cellular Therapies Inc (ITCI): Hedge Fund Sentiment Takes A Turn for the Worse
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Why Chesapeake, ITI Inc, Pier 1, BP, and Chevron are in the Spotlight
After two long and painful years, there might be some light at the end of the tunnel for long-term energy investors after OPEC agreed to cut production for the first time since...
Are Markets Finally Starting To See Intra-Cellular Therapies, Inc. (ITCI)’s Billion-Dollar Potential?
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) just announced that it has kicked off a phase 3 clinical trial for its lead neurological candidate, ITI-007-201.
Is Intra-Cellular Therapies Inc (ITCI) A Good Stock To Buy?
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the government.
